Clinical Psychology

The standing claim

Two levers decide value in this domain: the time between psychological need and effective therapeutic contact, and whether psychological care is built into physical-illness pathways rather than bolted on. Psychological suffering is the part of the encounter the biomedical record is least able to see — and the part most likely to determine whether treatment is sustained and whether a life feels worth living.

Where practice stands

England has, in NHS Talking Therapies (formerly IAPT), a genuinely world-leading achievement on one axis: measured access at scale. The service publishes session-by-session outcomes for over a million people a year and meets firm access standards — ≥75% to first treatment within 6 weeks, ≥95% within 18 weeks. But two gaps matter for this domain. First, recovery sits around the 50% expected standard, not comfortably above it. Second, there is no distinct standard for older adults or for people with long-term physical conditions — precisely the groups this publication tracks. Provision of clinical psychology inside acute and older-people’s services is thin and variable: the British Psychological Society reports on the order of ~1,000 WTE psychological professionals across acute hospital trusts in England, much of it on time-limited funding (BPS, citing the NHS Benchmarking census). The need is whole-person; the provision is patchy and rarely embedded where physical illness is treated.

What good looks like

“Good” is stepped, integrated, measurement-based care — and the outcome evidence for it is strong. According to PubMed, the IMPACT trial (Unützer et al., 2002 — RCT, n=1,801, age ≥60) found collaborative care for late-life depression roughly doubled response: 45% achieved ≥50% symptom reduction at 12 months vs 19% with usual care (OR 3.45, 95% CI 2.71–4.38), with better function and quality of life. A meta-analysis of 20 RCTs (n=4,774) found collaborative care improves not only depression but physical illness burden (OR 1.64, 95% CI 1.47–1.83) — the mind-body integration is not rhetorical (van Eck van der Sluijs et al., 2017). NICE recommends exactly this model — collaborative, stepped care for depression with a chronic physical health problem (CG91; NG222) — and structured psychosocial intervention (e.g. cognitive stimulation therapy) in dementia (NG97); these are authoritative recommendations, not statutory mandates.

The exemplar is chosen on outcomes and transferability, not reputation — and it does not need importing. The collaborative-care model has already been delivered inside NHS primary care, for a deprived-inclusive population, in the COINCIDE programme: low-intensity psychological treatment delivered by existing Talking Therapies practitioners alongside practice nurses, for people with depression and diabetes or heart disease, at a cost of £16,123 per QALY — below the NICE threshold (Camacho et al., 2016). So the model with the best evidence is also the one with NHS-native proof of feasibility and value. NHS Talking Therapies is the international exemplar for measured access; collaborative care is the exemplar for integrated provision in physical illness and older age — and the distance between the two is the work.

Through the lenses

The measure is use value — does the person feel more capable, less frightened, more themselves — not the count of contacts. This is the illness vs disease distinction (Kleinman) and McGilchrist’s whole-person attention made operational: the psychological dimension is the living context the record omits. The VAT lever is time-to-effective-contact and right-sizing the intervention to the need. Cross-domain, psychological capacity shapes outcomes in every other domain — delirium and distress in acute frailty (D01), the emotional labour of rehabilitation (D04), and existential distress in the last year of life (D03).

Confidence and limits

IMPACT is high-quality RCT evidence but from US primary care; its transferability is evidenced by COINCIDE within the NHS. The Talking Therapies access figures are firm operational standards; the recovery figures are expected outcome standards, not statutes. One honest gap: we did not find a clean primary study isolating referral-to-treatment delay as a predictor of psychology outcomes — so the case for speed rests on the access standards and the stepped-care rationale, not a specific effect size. The thinnest, least-measured part of the system is exactly the part this domain cares about most: psychology embedded in physical-health and older-people’s settings.

What we are watching

Whether NHS Talking Therapies sets explicit standards for older adults and long-term-conditions provision; the acute-hospital psychology workforce (size and funding stability); and whether collaborative care is commissioned at scale into physical-illness pathways rather than piloted and withdrawn.